Welcome to Scintellix!


Scintellix is a scientific and management consultancy located in Raleigh, NC.  Dedicated to
optimizing the human element in technology development, Scintellix supports both strategic and
tactical planning to optimize execution.  We do this through application of Decide-S3 Analytics-TM -
a novel methodology that clarifies decisions while aligning teams.
Scintellix untangles complex problems that prevent individuals, companies and institutions from
achieving their goals.








Who We Serve [Case Studies]

Our clients include:

  • Companies facing growth-related needs for
strategic and tactical planning to set the stage
for rapid execution, including Board Composition
Planning, Opportunity Stratification and Human
Resource Planning.

  • Educational and other non-profit institutions
requiring clarification of direction and
critical step management.

  • Government agencies requiring consensus-based
action plans and coordination of implementation.

  • Professionals who wish to undertake defined
career change planning.

The Benefits We Provide Include:

  • Rapid understanding of your technology environment,
human resource capabilities and challenges.
  • Rapid team agreement on consensus goals.
  • Strong implementation support.


    Contact: 919-844-0343                               info@scintellix.com

Recent
Accomplishments:

Facilitation of the
Strategic Planning
Process for the 37
University Clinical and
Translational Science
Award Program of the
National Center for
Research Resources.

Market Assessment
and Launch Initiation
(Including Sales Team
Recruitment and
Management) for an
FDA-Cleared Novel
Hemostatic Textile.

Board Composition
Planning for a
US-based Public
Company:  
Biotechnology/
Diagnostics Sector.

Board Composition
Planning for a
US-Based Public
Company: Education
Services Sector

Development of
Algorithm-Based
Technology Opportunity
Stratification for a
US-Based
Regenerative Medicine
Company

Facilitation of Municipal
Strategic Planning for a
Western Pennsylvania
Community

Leadership Planning
Summit for A Major
Provider of Physician
Practice Groups

January 26, 2010, to
"Beyond the Bench"
Graduate
Entrepreneurship
Class, University of
North Carolina at
Chapel Hill: "The
Professional Becomes
An Entrepreneur."

Speaking
Engagements:

February 4, 2010, to
Hannover, Germany
REBIRTH
(Regenerative
Medicine): "Strategic
Directions in Tissue
Engineering."

February 5, 2010, to
Medical School,
Hannover, Germany,
"Optimizing Your
Biomedical Research
Agenda."

June 13-17, 2010,
Galway, Ireland TERMIS
(Tissue Engineering &
Regenerative Medicine
International Society
Meeting): Participant in
Structured Debate.


Recent Books
Published:

Advances in Tissue
Engineering:
Angiogenesis (With A.
Mikos), Mary Ann
Liebert Publications,
2010.

Advances in Tissue
Engineering: Stem
Cells (With A. Mikos),
Mary Ann Liebert
Publications, 2010.

There's A Great Future
In Plastics, Scintellix
Publishing, 2010

See additional books at
Scintellix Publishing

Scintellix and Cryptography: The raison d'etre

Scintellix is in partnership with Genetic Engineering & Biotechnology News to create quarterly Cryptogram Challenges whose
themes derive from biomedical science.  These draw hundreds of participants together over a period of months to solve a
complex visual puzzle.  In this way, each serves as a motif for what we do when we apply Decide-S3 Analytics-TM  to
complex business problems - each requires a process of untangling information to achieve clarity.

The history of the series is available through these links:

1. MicroArray Challenge - 2008  Meet the winners, here.  Purchase the limited edition poster here.  
2. Cryptogram Challenge: Elisa - 2009  Meet the winners, here.  Purchase the limited edition shirt here.
3. Cryptogram Challenge: Elisa Redux - 2009  Meet the winners, here.
4. RNAi Cryptogram Challenge - 2010 - Recently solved!  The winner will be featured in an upcoming edition of Genetic
Engineering & Biotechnology News.

Note - In all cases but one thus far, the Cryptogram Challenges have been solved by teams.

Breaking News!  The RNAi-2 Cryptogram Challenge, the fifth in the series of Cryptogram Challenges has recently been
launched.  Created by Scintellix and Genetic Engineering & Biotechnology News, the RNAi-2 Cryptogram Challenge is
sponsored by Invitrogen.  The first 150 registrants will receive a special t-shirt that is decorated with an image derived from
the cryptogram itself, a process known as Scientific Derivative Art.  Whomever first cracks the code will receive $1,500 and a
bench top device from Invitrogen.  Register for the Challenge by clicking here.
Scintellix Home
Recent News:
Scintellix and Personalized
Medicine Partners
announce a partnership.

Genetic Engineering &
Biotechnology News and
Scintellix announce the
launch of the RNAi-2
Challenge, sponsored by
Invitrogen.